Accelerated biological aging linked to rising early-onset cancers in younger adults
New research suggests younger generations may be biologically older than their chronological age.
1Rising cancer in younger adults
Cancer diagnoses are increasing among younger adults, with each newer generation facing higher risks than the previous one. Researchers are investigating whether accelerated biological aging could explain this trend. A study by Washington University School of Medicine found evidence that younger generations show faster biological aging compared to older generations at the same chronological age. This suggests their cells may be accumulating damage more rapidly.
2Biological vs chronological age
The study measured the gap between biological age (based on cellular and physiological markers) and chronological age (years lived). Larger gaps were found in more recent generations, indicating their bodies appear biologically older. This difference was associated with increased cancer risk. Researchers used clinical biomarkers and proteomic data to assess aging across different organ systems.
3UK and US population findings
Analysis of 154,000 UK Biobank participants showed those born 1965-1974 had 23% higher systemic aging than 1950-1954 births. In the US All of Us program, 1990-1999 births showed 92% higher aging than 1965-1969 births. These generational differences persisted after accounting for chronological age, suggesting environmental or lifestyle factors may be accelerating biological aging.
4Cancer risk correlations
Greater systemic aging was linked to 8% higher risk of early-onset solid cancers (diagnosed ≤55 years). The strongest associations were for lung, gastrointestinal, and uterine cancers. Participants with most advanced aging had 15% higher cancer risk than those with least aging. These associations remained after adjusting for genetic cancer risks.
5Organ-specific aging patterns
Different aging rates in specific organs correlated with particular cancers. Advanced immune system aging was linked to early-onset lung cancer, while adipose tissue aging was associated with colorectal cancer. Researchers used blood proteomics to estimate organ-specific biological ages, revealing these targeted relationships.
6Measurement methodologies
The team employed multiple aging metrics: PhenoAge (9 blood markers), Klemera-Doubal Method, and metabolomic age scores for systemic aging. For organ-specific aging, they analyzed blood proteomic data measuring proteins associated with different biological systems. Standard deviation analysis quantified generational differences in aging rates.
7Potential clinical applications
Researcher Yin Cao suggests these aging biomarkers could help identify high-risk individuals before cancer develops, enabling earlier prevention strategies. The goal is to move from broad recommendations to personalized interventions based on an individual's biological aging profile. This could transform cancer prevention approaches.
8Ongoing research efforts
The study is part of Team PROSPECT, a Cancer Grand Challenges initiative investigating early-onset cancers. Researchers are examining how modern environments and lifestyles may leave biological marks that increase disease vulnerability. Future work will trace how these risks accumulate throughout life to uncover cancer origins.
9Broader implications
The findings suggest cancer risk may be influenced by whole-body changes, not just cellular mutations. Understanding accelerated biological aging could explain rising early-onset cancers worldwide. This research represents a shift toward preventive medicine by identifying at-risk individuals earlier in life when interventions may be most effective.